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Hormonal changes during and after pregnancy are linked with modifications in the
maternal microbiota. We describe the importance of the maternal microbiota in
pregnancy and examine whether changes in maternal microbiotic composition at
different body sites (gut, vagina, endometrium) are associated with pregnancy
complications. We analyze the likely interactions between microbiota and the immune
system. During pregnancy, the gastrointestinal (gut) microbiota undergoes profound
changes that lead to an increase in lactic acid–producing bacteria and a reduction in
butyrate-producing bacteria. The meaning of such changes needs clarification.
Additionally, several studies have indicated a possible involvement of the maternal gut
microbiota in autoimmune and lifelong diseases. The human vagina has its own
microbiota, and changes in vaginal microbiota are related to several pregnancy-related
complications. Recent studies show reduced lactobacilli, increased bacterial diversity,
and low vaginal levels of beta-defensin 2 in women with preterm births. In contrast, early
and healthy pregnancies are characterized by low diversity and low numbers of bacterial
communities dominated by Lactobacillus. These observations suggest that early vaginal
cultures that show an absence of Lactobacillus and polymicrobial vaginal colonization are
risk factors for preterm birth. The endometrium is not a sterile site. Resident endometrial
microbiota has only been defined recently. However, questions remain regarding the main
components of the endometrial microbiota and their impact on the reproductive tract
concerning both fertility and pregnancy outcomes. A classification based on endometrial
bacterial patterns could help develop a microbiota-based diagnosis as well asorg October 2020 | Volume 11 | Article 5282021
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treatments through nutritional, microbiotic, or pharmaceutical interventions.Keywords: microbiota, pregnancy, immunity, gut, vagina, endometrium, inflammasomeINTRODUCTION
The human body is host to a community of microorganisms,
including viruses, bacteria, and fungi. The bacterial component
of this community, the microbiota, is known to influence health
given its symbiotic relationship with the human host.
Vertical transmission of bacteria from mother to newborn
contributes to developing the microbiota of the infant
gastrointestinal (gut); emerging evidence suggests that this
influence may begin in utero (1).
Important changes in the maternal gut microbiota have been
observed during pregnancy. These changes are associated with
an increase in maternal body weight and dietary changes.
Physiological maternal metabolic modifications maintain
maternal hyperglycemia and provide glucose to the growing
fetus (2). The growth of bacterial species that can synthesize
glycogen is stimulated in the presence of increased
concentrations of glucose (3). In fact, the transcriptomic
pattern of the maternal gut microbiota shows microbiotic
changes related to hyperglycemia, especially in the third
trimester (4).
The maternal gut microbiota may influence the growth of
bacteria in the newborn’s gut, affecting its function and the
development of the immune system (5). How the microbiota
impacts the immune system in the short and long terms is a
critical concern. The microbiota is involved in the regulation of T
cell expansion, the development and function of macrophages,
and neutrophil chemotaxis (6–8). A major contribution to this
debate illustrates how the transient colonization of pregnant
female mice with engineered Escherichia coli may modify the
levels of intestinal innate immune composition in mother and
offspring. This suggests that gut maternal microorganisms may
play a role in the regulation of the immune system of newborns
(9). Vitamin synthesis, gut barrier function, and development of
the immune system are essential functions of human health that
develop alongside the expansion of the gut microbiota (9). Thus,
any changes in the maturation of the gut microbiota in the infant
may influence future bacterial colonization and the development
of the immune system with possible health consequences.
Despite various scholarly contributions on the maternal
microbiota in late pregnancy, only empirical evidence can
capture changes in the maternal microbiota at this stage. To
date, several factors have been known to influence the human
microbiota, such as ancestry, antibiotic use, lifestyle, dietary
habits, exercise frequency, and body mass index (BMI) (10).
This means that there is no unique health or disease indicator
related to the microbiota, yet each individual has a different
microbiota from that of others. Consequently, evaluating the
microbiota in early pregnancy or even before pregnancy may be a
useful tool to enable a personalized approach. Demonstrationorg 2that an altered microbiota may be linked to maternal and fetal
complications is an important target in personalized medicine.THE MATERNAL MICROBIOTA AND
PREGNANCY OUTCOMES
The Gastrointestinal Microbiota
During pregnancy, maternal fat deposition and food intake
increase progressively. In the second and third trimesters,
maternal metabolic changes include increased gluconeogenesis,
lipolysis, and insulin resistance. Such an acquired diabetogenic
condition is functional and induces maternal physiological
hyperglycemia, which, in turn, increases glucose availability for
the growing fetus. Therefore, significant changes in the maternal
gut microbiota occur during pregnancy (2, 4, 11). Although
scholars have explored the maternal microbiota in the third
trimester of pregnancy, data on the changes in maternal
microbiota during early pregnancy are scarce (2, 4, 11, 12).
The gut microbiota in the first trimester of pregnancy resembles
the microbiota of healthy nonpregnant women (2, 4, 11). Women
have unique gut microbiota that can be classified into different
classes or enterotypes. In turn, these are characterized by different
groups of bacteria (13, 14). Currently, three classes of enterotypes
are recognized, each with its dominant group of bacteria: enterotype
I, which is characterized by the presence of Bacteroides; enterotype
II, characterized by Prevotella; and enterotype III, dominated by
Ruminococcus. The three enterotypes have different and specific
functions, producing energy from carbohydrates or proteins (13,
14). A different enterotype characterizes each individual and can be
modified by various factors, including diet and BMI (15, 16).
Recently, Barret et al. (16) analyze the maternal intestinal
microbiota in early pregnancy by comparing an omnivorous diet
to a vegetarian one.Women consuming a vegetarian diet showed an
increase of bacterial clusters involved in lipid synthesis, which
suggests alteration of fermentation and presence of bacterial
species producing large amounts of short-chain fatty acids
(enterotype II). Studies on gut microbiota in a sample of African
women detect the prevalence of enterotype II (Prevotella). A diet
rich in vegetables with low consumption of animal proteins and
lipids allows the growth of bacterial clusters, which degrade the
mucin-type glycoproteins that cover the gut mucosal layer.
Conversely, a European diet rich in animal protein and lipids is
associated with enterotype I (Bacteroides). This enterotype produces
energy from proteins and carbohydrates (13, 14, 16).
An obese state has also been associated with microbiotic
composition during gestation (2, 11, 17). Levels of Bacteroides
and Staphylococcus are higher in the feces produced by
overweight pregnant women compared to those with a healthyOctober 2020 | Volume 11 | Article 528202
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women, insulin and adipokines (adipose tissue–derived
cytokines) correlate with alterations in bacterial abundance,
confirming an association between the microbiota and the level
of metabolic hormones and cytokines in pregnancy (18). The
pregestational BMI contributes to an increased risk of obstetric
complications through cellular and molecular processes that are
poorly understood (19). Normal placental development and
pregnancy success are largely dependent on angiogenic and
vascular remodeling events that take place within the
maternal–fetal interface (20–22). Several populations of
leukocytes in the decidual microenvironment control the early
stages of trophoblast invasiveness; uterine natural killer cells are
the most abundant immune cell subtype within the decidua (23–
26). These cells are key players in uterine vascular growth
through the production of proangiogenic factors and tissue-
remodeling cytokines (25–29). Obesity, accompanied by
increased adipose tissue richness in macrophages, T and B
lymphocytes, mast cells, and neutrophils, is associated with
altered levels of proinflammatory cytokines. In addition, obese
women show decreased levels of decidual uterine natural killer
cells with reduced production of proangiogenic factors (30, 31).
Several studies support the hypothesis that changes in the gut
microbiota during early pregnancy are associated with an
increased risk of gestational diabetes and hypertension (32–35).
Enriched abundance of Blautia and Ruminococcus has been
observed in patients with diabetes (35). Gomez-Arango et al.
(36) find that the abundance of Odoribacter, a butyric acid–
producing bacterium, is negatively correlated with systolic blood
pressure in pregnant women at 16 weeks of pregnancy. Lv et al.
(35) find an important association between alterations in gut
microbiota (dysbiosis) and early-onset preeclampsia (PE). They
show that the composition of gut microbiota in patients with
early-onset PE differed significantly from that in healthy
pregnant women. They identified that the bacteria associated
with PE were also associated with other host morbidities,
including obesity, higher incidence of glucose metabolic
disorders, proinflammatory states, and intestinal barrier
dysfunction. In addition, these microorganisms correlated with
host immune parameters, such as interleukin-6 and
lipopolysaccharide (LPS), the major component of the outer
membrane of Gram-negative bacteria. Overall, these findings
suggest that an altered gut microbiota during early pregnancy (by
acting on the maternal immune system and affecting the
production of proinflammatory cytokines) may be involved in
the development of pregnancy-related complications, such as
early-onset PE.
In a recent study, we hypothesized that, if abnormal bacterial
translocation across the epithelium occurs early in pregnancy
(with LPS being a marker of increased bacterial translocation
across the intestinal epithelium), then uterine innate immunity
and obstetric outcome may be affected. We find that increased
intestinal permeability in early pregnancy is associated with
increased maternal levels of LPS, excessive inflammasome-
mediated production of cytokines at the endometrial level, and
last, increased risk of pregnancy loss (37, 38). Therefore, weFrontiers in Immunology | www.frontiersin.org 3suggest that, during early pregnancy, gut bacterial products from
the intestinal lumen are translocated into the maternal
circulation. This is likely associated with increased intestinal
permeability and may increase the risk of obstetric complications
(Figure 1).
During the third trimester of pregnancy, butyrate-producing
bacteria with anti-inflammatory activities decline, whereas
bifidobacteria, proteobacteria, and lactic acid–producing
bacteria increase (2, 4, 11, 39). Additionally, the maternal gut
microbiota grows less actively, reaching a stationary phase
accompanied by reduced gut motility and increased intestinal
permeability (2, 11, 39). Gastrointestinal modifications in the
third trimester concern the host immune system of the
gastrointestinal mucosa. Together with changes in metabolic,
hormonal, and gastrointestinal permeability, these modifications
may increase the diffusion of glucose from the gut epithelium
toward the lumen and bacterial translocation. Collectively, these
changes impact the composition of the gut microbiota and,
consequently, maternal weight gain (4, 39, 40). Some of the
proposed mechanisms by which the gut microbiota plays a role
in host weight gain during pregnancy include enhanced
absorption of glucose and fatty acids, increased fasting-induced
adipocyte factor secretion, induction of catabolic pathways, and
immune system stimulation (2, 11, 17, 39, 40).
The meaning of modifications in the gut microbiota has been
investigated (2, 11, 41, 42). Notably, fecal transplantation of first-
and third-trimester fecal microbiotas to germ-free mice revealed
that mice transplanted with third-trimester microbiota gained
significantly more weight, developed insulin resistance, and had
a greater inflammatory response compared to mice transplanted
with first trimester-microbiota (11). These findings demonstrate
the direct role of microbiotic components in inducing changes in
host immunology and metabolism. Interestingly, such
modifications resemble those seen in metabolic syndrome,
despite occurring in a physiological rather than pathological
condition, such as being 7–9 months pregnant.
The gut microbiota during pregnancy is a critical determinant
of offspring health (5, 18, 41, 42). Potentially, it determines the
development of atopy and autoimmune phenotypes in the
offspring (5). The commensal microbiota has a role in
regulating host immunity to pathogens and autoimmune
responses. Indeed, the microbiota is a source of metabolites
and peptide ligands for T cell recognition, known as pathogen-
associated molecular patterns (PAMPs), which are recognized by
immune receptors. Microbiota-derived metabolites and PAMPs
can affect target organs and activate the autoimmune cascade.
This does not start after birth but may occur in the womb,
engendering a predisposition of the progeny to disease (43).
Despite this, the relationship between the immune system, gut
microbiota, and metabolism of pregnant women is unclear.
The Vaginal Microbiota
The vaginal microbiota changes throughout a woman’s
reproductive life from puberty to menopause with variations
during the menstrual cycle (44). In the healthy female
reproductive tract, lactobacilli are dominant. One of the keyOctober 2020 | Volume 11 | Article 528202
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Glycogen produced by vaginal epithelial cells is transformed into
lactic acid, inducing a low vaginal pH (3.8–4.4). This creates an
unfavorable environment for the growth of pathogenic bacteria
(45). Vaginal dysbiosis, which is linked to inflammatory states, is
associated with adverse obstetric outcomes (Figure 2) (46). In the
presence of dysbiosis, the vaginal microbiota increases the levels of
vaginal inflammatory cytokines, which, in turn, increases the risk of
spontaneous preterm birth (sPTB) (46–48). However, the debate on
the relationship between vaginal dysbiosis and an increased risk of
obstetric complications is ongoing. Several studies on the vaginal
microbiota and sPTB rely on small sample sizes, primarily because
data on vaginal swabs throughout pregnancy are often absent;
where they exist, they show limited information on sPTB.
Alterations in lactobacilli dominance are likely to influence a
patient’s reproductive potential. In the presence of a microbiota
with high bacterial diversity, as in bacterial vaginosis, an
increased risk of infections, sPTB, and pelvic inflammatory
disease have been observed (47–56). Consistent with these
data, an increased risk of sPTB was detected in patients with
low levels of Lactobacillus and increased bacterial diversity with
Gardnerella vaginalis and Mycoplasma (47–56). Presence of
Lactobacillus and low bacterial diversity were detected in
women with term deliveries (56, 57). Lactobacillus iners is a
risk factor for sPTB in high-risk patients; however, some studies
suggest that the presence of Lactobacillus crispatus in the vaginalFrontiers in Immunology | www.frontiersin.org 4microbiota is protective against sPTB (56, 57). Because sPTB
might be related to pathogenic microbes able to ascend from the
vagina, these observations suggest that early characterization of
the vaginal microbiota might be a predictive marker for obstetric
complications, such as sPTB.
The relationship between the vaginal microbiota and obstetric
complications is population-dependent. Women of European
ancestry are more likely to harbor a Lactobacillus-dominated
microbiome, whereas African American women are more likely
to exhibit a diverse microbiotic profile. These women are also twice
as likely to be diagnosed with bacterial vaginosis and twice as likely
to experience preterm birth (53). By comparing African American
women with women of European ancestry, Fettweis et al. (53) find
that vaginal microbiotic diversity is significantly greater in African
American women. In these women, the most common profile was
L. iners followed by G. vaginalis, Candidatus Lachnocurva vaginae
(also known as bacterial vaginosis-associated bacterium 1), and L.
crispatus. In contrast, the most common profile in women of
European ancestry was L. crispatus, followed by L. iners and G.
vaginalis. These results suggest that there are significant differences
in vaginal microbiota related to ancestry (53); such differences
might explain the observed prevalence of bacterial vaginosis and
preterm birth. Vaginal dysbiosis is associated with increased levels
of proinflammatory cytokines (58). Recently, Fettweis et al. (53)
observed that levels of the vaginal inflammatory cytokine CXCL10
were related to the L. crispatus/L. iners ratio in patients at increasedOctober 2020 | Volume 11 | Article 5282FIGURE 1 | The gastrointestinal (gut) microbiota. During pregnancy, the gut microbiota undergoes profound changes with different enterotypes characterizing each
woman. If abnormal bacterial translocation across the epithelium that is associated with increased levels of LPS occurs during early pregnancy, uterine innate
immunity and obstetric outcome may be affected. Abnormally increased intestinal permeability during early pregnancy is associated with increased levels of
circulating bacterial products and cytokines. Both events might increase inflammasome activation at the endometrial level; consequently, they increase the risk of
obstetric complications during early pregnancy (figure created with BioRender.com).02
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predictive marker for sPTB. However, the difference between
preterm and term deliveries cannot be explained only by a lack
of Lactobacillus species given that many women deliver at term
despite lacking Lactobacillus species. Conversely, the presence of
Lactobacillus species does not guarantee a term birth, suggesting
that there may be a risk associated with other causes of sPTB.
Recently, Elovitz et al. (55) show that immune factors, such as beta-
defensin 2, can modulate the risk independently of the presence or
absence of Lactobacillus species. Indeed, high vaginal levels of beta-
defensin 2 have been shown to lower the risk of sPTB. However,
the reasons why some women have high or low beta-defensin 2
levels are unknown.
Despite research efforts, sPTB is one of the most common
causes of neonatal death and infant mortality with consequences
persisting from early childhood into adulthood; this presents
families and society with important emotional and financial
costs. Existing empirical evidence suggests that future
population-specific studies may be able to shed light on theFrontiers in Immunology | www.frontiersin.org 5role of the vaginal microbiota, thereby supporting the
development of therapeutic strategies. These include immune
modulators and microbiome-based therapeutic approaches.
The Endometrial Microbiota
The endometrium is a site of immune surveillance where
different components from the immune system work together
to prevent infections and allow implantation of the blastocyst
during pregnancy (59–61). When pregnancy begins, the
endometrium undergoes decidualization; modifications in
immune cell composition also occur (59–64). The local
immune response, influenced by ovarian steroids, is essential
for successful blastocyst implantation. Alteration of the
endometrial immunological response during pregnancy has
been linked to pregnancy complications, such as early
pregnancy loss, preterm delivery, PE, and fetal growth
restriction (Figure 3) (65–69).
The endometrium is not a sterile site. Recently, due to the
sequencing of specific regions of bacterial ribosomal RNA, aFIGURE 2 | The vaginal microbiota. The vaginal microbiota is composed of a variety of bacterial species. Alterations in lactobacilli dominance and a microbiota with high
bacterial diversity are associated with an increased risk of infections, spontaneous preterm birth, and pelvic inflammatory disease (figure created with BioRender.com).October 2020 | Volume 11 | Article 528202
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(70–73). Early studies on the endometrial microbiota reported the
dominance of Lactobacillus species. Moreno et al. (74, 75) report an
association between low levels of Lactobacillus species (<90%
Lactobacillus with >10% other bacteria) in the endometrial
microbiota and poor pregnancy outcomes regarding implantation
success and ongoing and term pregnancy rates. A further study
describes an endometrial microbiota mainly dominated by
Bacteroides (76). Nevertheless, the heterogeneous characteristics of
the women included in these studies (obstetric history, number of
previous termdeliveries, demographics, andmedical history) limited
this research. More recently, the endometrial microbiota obtained
from the tip of the transfer catheter in 70women undergoing in vitro
fertilization was analyzed (77). In line with other studies,
vaginal bacterial Lactobacillus species were dominant (>70%
abundance). Furthermore, Corynebacterium, Bifidobacterium,
Staphylococcus, and Streptococcus were observed (73, 78).
However, a key limitation of the study was the heterogeneity of
the population analyzed.
Winters et al. (79) recently questioned these observations.
They suggest that the transcervical catheter collection of
endometrial microbiota used in previous research was more
prone to contamination. To overcome this, they obtained
endometrial samples from hysterectomies and found an
endometrial microbiota mainly composed of Acinetobacter,
Pseudomonas, Cloacibacterium, and Comamonadaceae.
Notably, they report that Lactobacillus was rare in the
endometrial samples they analyzed. Finally, endometrial
bacterial composition was different from that of the vagina.Frontiers in Immunology | www.frontiersin.org 6Instead, it was correlated to that of the cervix regarding
composition and bacterial load. To date, the role of the
endometrial microbiota in female reproduction is not fully
understood. Liu et al. (80) try to link endometrial microbiota
to chronic endometritis (CE) (81–84). The gold standard for the
diagnosis of CE relies on histological identification of plasma
cells in the endometrial stroma (84). The impact of CE on
reproductive capacity is not well known. The prevalence of CE
in the general population ranges from 0.8% to 19%. This
percentage reaches 30%–45% in patients who are infertile or
experience recurrent pregnancy loss (85–90). The mechanisms
involved in CE-related poor pregnancy outcomes include
imbalance in immune cell composition in the endometrium,
lower response to steroid hormones, impairment in glycodelin
secretion, and altered expression of pinopodes (91–94).
Liu et al. (80) compare the endometrial microbiota of infertile
women with and without CE. They obtained endometrial
biopsies and postovulatory-phase endometrial fluid from 130
infertile women. They found that CE was strictly associated with
an increased proportion of non-Lactobacillus bacterial taxa in the
endometrial cavity although the mechanisms underlying such a
correlation are unknown.
Additionally, several recent studies suggest the presence of a
resident microbiota in the endometrium (95–97). Yet studies
that evaluate the role of the endometrial microbiota on
reproductive health are in their infancy. We speculate that the
endometrial microbiota may interact with the endometrial
epithelium and endometrial immune cells, ultimately resulting
in impaired endometrial receptivity and defective implantation.FIGURE 3 | The endometrial microbiota. The endometrium is not a sterile tissue. Resident populations of microorganisms at the endometrial level have been observed. It
is possible that these microorganisms might interact with the endometrial epithelium and/or alter endometrial expression of leukocytes and cytokines. Therefore, these
events, either in isolation or acting together, may impair endometrial receptivity and affect adequate implantation (figure created with BioRender.com).October 2020 | Volume 11 | Article 528202
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bacteria to colonize the endometrium and/or establish a commensal/
pathogenic relationship with intrauterine tissues (98, 99).CONCLUSIONS
The human microbiota plays a central role in health and female
morbidity. Therefore, classifying women based on bacterial patterns
would allow a personalized, microbiota-based diagnosis, which could
then be used to develop personalized therapies for disease prevention
and personalized treatments. These treatments could be used to
modulate the composition of the microbiota. Women planning to
have a family could be asked to consume specific nutrients, foods,
and probiotics as well as making appropriate lifestyle changes.
Pharmaceutical intervention is another useful adjunct.Frontiers in Immunology | www.frontiersin.org 7AUTHOR CONTRIBUTIONS
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41. Donnet-Hughes A, Perez PF, Doré J, Leclerc M, Levenez F, Benyacoub J, et al.
Potential role of the intestinal microbiota of the mother in neonatal immune
education. Proc Nutr Soc (2010) 69(3):407–15. doi: 10.1017/S002966511
0001898
42. Dunlop AL, Mulle JG, Ferranti EP, Edwards S, Dunn AB, Corwin EJ. Maternal
Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review. Adv
Neonatal Care (2015) 15(6):377–85. doi: 10.1097/ANC.0000000000000218
43. Yurkovetskiy LA, Pickard JM, Chervonsky AV. Microbiota and
autoimmunity: exploring new avenues. Cell Host Microbe (2015) 17:548–52.
doi: 10.1016/j.chom.2015.04.010
44. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal
microbiome of reproductive-age women. Proc Natl Acad Sci USA (2011) 108
Suppl 1:4680–7. doi: 10.1073/pnas.1002611107
45. Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as
biomarkers and agents that can promote various aspects of vaginal health.
Front Physiol (2015) 6:81. doi: 10.3389/fphys.2015.00081
46. Anahtar MN, Gootenberg DB, Mitchell CM, Kwon DS. Cervicovaginal
Microbiota and Reproductive Health: The Virtue of Simplicity. Cell Host
Microbe (2018) 23:159–68. doi: 10.1016/j.chom.2018.01.013
47. Hyman RW, Fukushima M, Jiang H, Fung E, Rand L, Johnson B, et al.
Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci
(2014) 21(1):32–40. doi: 10.1177/1933719113488838Frontiers in Immunology | www.frontiersin.org 848. Fettweis JM, Serrano MG, Brooks JP, Edwards DJ, Girerd PH, Parikh HI, et al.
The vaginal microbiome and preterm birth. Nat Med (2019) 25:1012–21.
doi: 10.1038/s41591-019-0450-2
49. Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM. Targeted
PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin
Microbiol (2007) 45:3270–6. doi: 10.1128/JCM.01272-07
50. Chavoustie SE, Eder SE, Koltun WD, Lemon TR, Mitchell C, Nyirjesy P, et al.
Experts explore the state of bacterial vaginosis and the unmet needs facing
women and providers. Int J Gynaecol Obstet (2017) 137:107–9. doi: 10.1002/
ijgo.12114
51. Di Giulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska
A, et al. Temporal and spatial variation of the human microbiota during
pregnancy. Proc Natl Acad Sci USA (2015) 112:11060–5. doi: 10.1073/
pnas.1502875112
52. Callahan BJ, Di Giulio DB, Goltsman DSA, Sun CL, Costello EK, Jeganathan
P, et al. Replication and refinement of a vaginal microbial signature of preterm
birth in two racially distinct cohorts of US women. Proc Natl Acad Sci U S A
(2017) 114(37):9966–71. doi: 10.1073/pnas.1705899114
53. Fettweis JM, Brooks JP, Serrano MG, Sheth NU, Girerd PH, Edwards DJ, et al.
Differences in vaginal microbiome in African American women versus
women of European ancestry. Microbiology (2014) 160:2272–82.
doi: 10.1099/mic.0.081034-0
54. Brown RG, Al-Memar M, Marchesi JR, Lee YS, Smith A, Chan D, et al.
Establishment of vaginal microbiota composition in early pregnancy and its
association with subsequent preterm prelabor rupture of the fetal membranes.
Transl Res (2019) 207:30–43. doi: 10.1016/j.trsl.2018.12.005
55. Elovitz MA, Gajer P, Riis V, Brown AG, Humphrys MS, Holm JB, et al.
Cervicovaginal microbiota and local immune response modulate the risk of
spontaneous preterm delivery. Nat Commun (2019) 10(1):1305. doi: 10.1038/
s41467-019-09285-9
56. Abdelmaksoud AA, Koparde VN, Sheth NU, Serrano MG, Glascock AL,
Fettweis JM, et al. Comparison of Lactobacillus crispatus isolates from
Lactobacillus-dominated vaginal microbiomes with isolates from
microbiomes containing bacterial vaginosis-associated bacteria.
Microbiology (2016) 162:466–75. doi: 10.1099/mic.0.000238
57. Stout MJ, Zhou Y, Wylie KM, Tarr PI, Macones GA, Tuuli MG. Early
pregnancy vaginal microbiome trends and preterm birth. Am J Obstet
Gynecol (2017) 217:356.e1–356.e18. doi: 10.1016/j.ajog.2017.05.030
58. Campisciano G, Zanotta N, Licastro D, De Seta F, Comar M. In vivo
microbiome and associated immune markers: New insights into the
pathogenesis of vaginal dysbiosis. Sci Rep (2018) 8:2307. doi: 10.1038/
s41598-018-20649-x
59. Kitaya K, Yasuo T, Tada Y, Hayashi T, Iwaki Y, Karita M, et al. Unusual
inflammation in gynecologic pathology associated with defective endometrial
receptivity. Histol Histopathol (2014) 29(9):1113–27. doi: 10.14670/HH-
29.1113
60. Park DW, Yang KM. Hormonal regulation of uterine chemokines and
immune cells. Clin Exp Reprod Med (2011) 38(4):179–85. doi: 10.5653/
cerm.2011.38.4.179
61. Robertson SA, Chin PY, Glynn DJ, Thompson JG. Peri-conceptual cytokines–
setting the trajectory for embryo implantation, pregnancy and beyond. Am J
Reprod Immunol (2011) 66 Suppl 1:2–10. doi: 10.1111/j.1600-
0897.2011.01039.x
62. Spencer TE, Hayashi K, Hu J, Carpenter KD. Comparative developmental
biology of the mammalian uterus. Curr Top Dev Biol (2005) 68:85–122.
doi: 10.1016/S0070-2153(05)68004-0
63. Figueira PG, Abrão MS, Krikun G, Taylor HS. Stem cells in endometrium and
their role in the pathogenesis of endometriosis. Ann N Y Acad Sci (2011)
1221:10–7. doi: 10.1111/j.1749-6632.2011.05969.x
64. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive
immunity in female genital tract: cellular responses and interactions. Immunol
Rev (2005) 206:306–35. doi: 10.1111/j.0105-2896.2005.00287.x
65. Vinketova K, Mourdjeva M, Oreshkova T. Human Decidual Stromal Cells as a
Component of the Implantation Niche and a Modulator of Maternal
Immunity. J Pregnancy (2016) 2016:8689436. doi: 10.1155/2016/8689436
66. Liu S, Diao L, Huang C, Li Y, Zeng Y, Kwak-Kim JYH. The role of decidual
immune cells on human pregnancy. J Reprod Immunol (2017) 124:44–53.
doi: 10.1016/j.jri.2017.10.045October 2020 | Volume 11 | Article 528202
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